Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of medications that are newly approved or medications with newly approved indication(s). This list can be found on HSA’s website.
December 2021
- New drugs approved: 3
- New drug indications approved: 2
New drugs approved
| Product name | Active ingredient(s) | Dosage Form | Strength of dosage form | Route of Administration | Indication(s) | Pharmaceutical company | Approval Date |
| Oncaspar | Pegaspargase | Vial | 750 U/mL | Injection | A component of anti-neoplastic combination therapy in acute lymphoblastic leukaemia (ALL) | Servier | 27 Dec 2022 |
| Nufilong | Pegfilgrastim | Pre-Filled Syringe/Pen | 6mg/0.6mL | Injection | Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes). | Pharma To Market | 07 Dec 2022 |
| Comirnaty | Tozinameran | Vial | 30mcg, 10mcg | Injection | Active immunisation to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 5 years of age and older | BioNTech Pharmaceuticals Asia Pacific | 10 Dec 2022 |
New drug indications approved
| Product name | Active ingredient(s) | Dosage Form | Strength of dosage form | Route of Administration | Indication(s) | Pharmaceutical company | Approval Date |
| Humira | Adalimumab | Multiple | Multiple | Injection | Paediatric Ulcerative Colitis | AbbVie | 22 Dec 2022 |
| Spravato | Esketamine | Vial | 28mg per vial | Inhalation | Indicated in adults with a moderate to severe episode of Major Depressive Disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms | Johnson & Johnson | 08 Dec 2022 |
